Zinc-α2-Glycoprotein: Is There Association between This New Adipokine and Body Composition in Hemodialysis Patients?

REFERENCES

• Fouque D, Kalantar-Zadeh K, Kopple J, . A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73: 391–398.
   PubMed Web of Science ®Google Scholar
• Pupim LB, Flakoll PJ, Iklizer TA. Protein homeostasis in chronic hemodialysis patients. Curr Opin Clin Nutr Metab Care. 2004;7: 89–95.
   PubMed Web of Science ®Google Scholar
• Carrero JJ, Chmielewski M, Axelsson J, . Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr. 2008;27:557–564.
   PubMed Web of Science ®Google Scholar
• Axelsson J, Qureshi R, Suliman ME, . Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr. 2004;80:1222–1229.
   PubMed Web of Science ®Google Scholar
• Ramos LF, Shintani AF, Iklizler TA, Himmerfarb J. Oxidative stress and inflammation are associated with adiposity to moderate to severe CKD. J Am Soc Nephrol. 2008;19:593–599.
   PubMed Web of Science ®Google Scholar
• Gohda T, Gotoh H, Tanimoto M, . Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Hypertens Res. 2008;31:83–88.
   PubMed Web of Science ®Google Scholar
• Cordeiro AC, Qureshi AR, Stenvinkel P, . Abdominal fat deposition is associated with increased inflammation, protein–energy wasting and worse outcome in patients undergoing hemodialysis. Nephrol Dial Transplant. 2010;25:362–368.
   Web of Science ®Google Scholar
• Bing C, Bao Y, Jenkins J, . Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA. 2004;101:2500–2505.
   PubMed Web of Science ®Google Scholar
• Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P. Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SBGS) adipocytes. FEBS Lett. 2005;579: 41–47.
   PubMed Web of Science ®Google Scholar
• Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res. 1998;58: 2359–2365.
   PubMed Web of Science ®Google Scholar
• Russel ST, Tisdale MJ. Antidiabetic properties of zinc-alpha2-glycoprotein in ob/ob mice. Endocrinology. 2010;151:948–957.
   PubMed Web of Science ®Google Scholar
• Russell ST, Zimmerman TP, Domin BA, Tisdale MJ. Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein, Biochim. Biophys Acta. 2004;1636:59–68.
   PubMed Web of Science ®Google Scholar
• Gong FY, Zhang SY, Deng JY, . Zinc-alpha2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. Int J Obes. 2009;33:1023–1030.
   Web of Science ®Google Scholar
• Bing C, Russel ST, Beckett EE, . Expression of uncoupling proteins-1, ‐2 and ‐3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. Br J Cancer. 2002;86:612–618.
   PubMed Web of Science ®Google Scholar
• Sanders PM, Tisdale MJ. Effect of zinc-α2-glycoprotein (ZAG) on expression of uncoupling proteins in skeletal muscle and adipose tissue. Cancer Lett. 2004;212:71–81.
   PubMed Web of Science ®Google Scholar
• Russel ST, Tisdale MJ. Mechanism of attenuation of skeletal muscle atrophy by zinc-α2-glycoprotein. Endocrinology. 2010; 151:4696–4704.
   PubMed Web of Science ®Google Scholar
• Ceperuello-Mallafré V, Naf S, Escoté X, . Circulating and adipose tissue gene expression of zinc-α2-glycoprotein in obesity: Its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat. Endocrine Res. 2009;94: 5062–5069.
   Google Scholar
• Selva DM, Lecube A, Hernández C, Baena JA, Fort JM, Simó R. Lower zinc-α2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. Endocrine Res. 2009;94:4499–4507.
   Google Scholar
• Yeung DCY, Lam KSL, Wang Y, Tso AWK, Xu A. Serum zinc-α2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. Endocrine Res. 2009;94:2531–2536.
   Google Scholar
• Olofsson LE, Olsson B, Lystig T, . Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids. Metab Clin Exp. 2010;59: 1316–1318.
   PubMed Web of Science ®Google Scholar
• Phillipp A, Kralisch S, Bachmann A, . Serum levels of the adypokine zinc-α2-glycoprotein are increased in chronic hemodialysis. Metab Clin Exp. 2011;60:669–672.
   PubMed Web of Science ®Google Scholar
• Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign: Human Kinetic; 1998.
   Google Scholar
• World Health Association/FAO. Expert Consultation on Diet Nutrition and the Prevention of Chronic Diseases. Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation. Geneva: World Health Consultation; 2003.
   Google Scholar
• Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981;34: 2540–2545.
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program. Executive summary of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Diet Assoc. 2001;285:2486–2497.
   Google Scholar
• Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from Skinfold thickness: Measurements on 481 men and woman aged from 16 to 72 years. Br J Nutr. 1974;32:77–79.
   PubMed Web of Science ®Google Scholar
• Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign: Abridged; 1991.
   Google Scholar
• Sargent JA, Gotch FA. Principles and biophysics of dialysis. In: Drukker W, Parsons FM, Maher JA, eds. Replacement of Renal Function by Dialysis. Hague: Martinues Nijhoff; 1985:53.
   Google Scholar
• Tabela Brasileira de Composição de Alimentos – TACO. Campinas, Universidade Estadual de Campinas; 2006.
   Google Scholar
• Ishimura E, Okuno S, Kim M, . Increasing body fat mass in the first year on hemodialysis. J Am Soc Nephrol. 2001;12:1921–1926.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Yuasa S, Fukunaga M, . Long-term evaluation of nutritional status using dual-energy X-ray absorptiometry in chronic hemodialysis patients. Clin Nephrol. 2003;59:373–378.
   PubMed Web of Science ®Google Scholar
• Spanner E, Suri E, Heidenheim P, Lindsay RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis. 2003;42:S30–S35.
   PubMed Web of Science ®Google Scholar
• Pupim LB, Heimburguer O, Qureshi AR, Ikizler TA, Stenvinkel P. Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int. 2003;42:295–302.
   Google Scholar
• Antuna-Punte B, Feve B, Fellahi S, Bastard JD. Adipokines: The missing link between insulin resistance and obesity. Diab Metabol. 2008;34:2–11.
   PubMed Web of Science ®Google Scholar
• Shastri S, Sarnak MJ. Cardiovascular disease and CKD: Core curriculum 2010. Am J Kidney Dis. 2010;56:399–417.
   PubMed Web of Science ®Google Scholar
• Vanholder R, Glorieux G, Van Biesen W. Advantages of new hemodialysis membranes and equipment. Clin Pract. 2010;114:165–172.
   Google Scholar
• Stejskal D, Karpísek M, Reutová H, Stejskal P, Kotolová H, Kollár P. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA. Clin Biochem. 2008;41:313–316.
   PubMed Web of Science ®Google Scholar
• Marrades MP, Martínez JA, Moreno-Allaga MJ. ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. J Physiol Biochem. 2008;64:61–66.
   PubMed Web of Science ®Google Scholar
• Dahlman I, Kaaman M, Olsson T, . A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab. 2005; 90:5834–5840.
   PubMed Web of Science ®Google Scholar
• Bing C, Mracek T, Gao D, Trayhurn P. Zinc-α2-glycoprotein: An adipokine modulator of body fat mass? Int J Obes. 2010;34: 1559–1565.
   Web of Science ®Google Scholar
• Fukagawa M, Iwasaki Y, Kazama JJ. Skeletal resistance to parathyroid hormone as a background abnormality in uremia. Nephrology. 2003;8:S50–S52.
   PubMed Web of Science ®Google Scholar
• Chen Y, Biada J, Sood S, Rabkin R. Uremia attenuates growth hormone-stimulated insulin-like growth factor-1 expression, a process worsened by inflammation. Kidney Int. 2010;78:89–95.
   PubMed Web of Science ®Google Scholar
• Carrero JJ, Wistap A, Stenvinkel P, . Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acid and triglyceride levels. Nephrol Dial Transplant. 2010;25:901–906.
   PubMed Web of Science ®Google Scholar
• Islam-Ali BS, Tisdale MJ. Effect of a tumor-produced lipid-mobilizing factor on protein synthesis and degradation. Br J Cancer. 2001;84:1648–1655.
   PubMed Web of Science ®Google Scholar
• Workeneh BT, Mitch WE. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr. 2010;91: S1128–S1132.
   PubMed Web of Science ®Google Scholar
• Kerr PG, Strauss BJG, Atkins RC. Assessment of the nutritional state of dialysis patients. Blood Purif. 1996;14:121–126.
   Web of Science ®Google Scholar
• Kamimura MA, Avesani CM, Cenderoglo M, Canziani ME, Draibe S, Cuppari L. Comparison of skinfold thicknesses and bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body fat in patients on long-term hemodialysis therapy. Nephrol Dial Transplant. 2003;18:101–105.
   PubMed Web of Science ®Google Scholar